Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 3604156

Swa: a subdivision.

M Contreras·P Teesdale·M Moulds·J Moulds·C Green·P Tippett·H Kaita·M Lewis
View original source ↗Export metadata ↓

Abstract

For some time, anomalous serological reactions have been observed when the same anti-Swa sera are tested against red cells from different individuals reported as Sw(a+). A comparative collaborative study using the same collection of Sw(a+) cells and anti-Swa sera was undertaken by 4 reference laboratories, and it was found that Swa represents a heterogeneous group of antigens that can be subdivided into two categories. Both categories, Sw(a+) 700:41 and Sw(a+) 700:-41, were shown to be inherited.

Explore related subjects

Blood Group AntigensHumansIsoantibodiesIsoantigensTerminology as TopicJournal ArticleResearch Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Contreras, P Teesdale, M Moulds, J Moulds, C Green, P Tippett, H Kaita, M Lewis. 1987. Swa: a subdivision.. https://doi.org/10.1111/j.1423-0410.1987.tb03004.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1998

Synthesis of a new neoglycolipid (AgH-1) and its effect upon the properties of dipalmitoylphosphatidylcholine: cholesterol liposomes.

A new neoglycolipid (AgH-1) bearing carbohydrate units that mimics the antigenic determinant of the O-blood group was synthesized and the effect of its incorporation in dipalmitoylphosphatidylcholine (DPPC): cholesterol liposomes was evaluated. The results obtained show that AgH-1 is readily incorporated into DPPC:cholesterol liposomes. The conditions leading to the optimal incorporation are the result of a compromise between incorporation efficiency and incorporation extent. The presence of AgH-1 produces liposomes of smaller size, with only small changes in the properties of the bilayer. However, the data obtained employing diphenylhexatriene and laurodan as fluorescence probes and merocyanine 540 as optical probe suggest that AgH-1 incorporation leads to a small rigidization of the liposomes at temperatures lower than ca. 42 degrees C.

Blood Group Antigens↗
PubMed1998

Molecular alterations in bladder cancer.

In recent years, significant information has been accumulated on the molecular alterations that take place during development of transitional cell carcinoma (TCC). A number of studies aimed at defining loss of heterozygosity have shown a general chromosomal instability in TCC with loss of parts of chromosome 9 at early stages of papillomas, and of chromosomes 11, 13, 3, 4, 8, 17 and 18 during further development of the tumor. Oncogenes are activated, exemplified by mutations in the ras gene family and overexpression of the c-erbB-2 gene, in a minor fraction of tumors. Alterations of tumor suppressors (involved in control of the cell cycle, DNA quality control and activation of apoptosis) seem to be frequently involved. Among these p53 has a key role, and one p53 allele is frequently lost in TCC followed by mutation of the remaining allele.These alterations are correlated with survival, disease progression, invasion and recurrence. Also frequently lost are the cell cycle control genes p16 and p15. The predictive value of this has not yet been determined. Studies of glycosylation genes have shown downregulation of the ABO gene, followed by loss of ABO blood group structures and accumulation of the Lewis cell adhesion molecules in high grade tumors. Functional proteome analysis has furthermore identified biomarkers that are correlated with grade and stage. Molecular models for TCC development can now be built, and clinical testing of these is urgently needed.

Blood Group Antigens↗